Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Gynecomastia × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Breast 1

Conditions

Prostatic Neoplasms 6198 Carcinoma, Renal Cell 1895 Urinary Bladder Neoplasms 1658 Kidney Neoplasms 922 Breast Neoplasms 786 Neoplasms 780 Carcinoma, Transitional Cell 584 Carcinoma, Non-Small-Cell Lung 517 Neoplasm Metastasis 505 Melanoma 482 Ovarian Neoplasms 463 Colorectal Neoplasms 449 Lung Neoplasms 433 Pancreatic Neoplasms 323 Testicular Neoplasms 287 Stomach Neoplasms 273 Sarcoma 265 Uterine Cervical Neoplasms 261 Non-Muscle Invasive Bladder Neoplasms 260 Head and Neck Neoplasms 239 Colonic Neoplasms 217 Esophageal Neoplasms 203 Squamous Cell Carcinoma of Head and Neck 198 Carcinoma, Hepatocellular 195 Wilms Tumor 194 Endometrial Neoplasms 188 Recurrence 158 Neuroblastoma 147 Urologic Neoplasms 145 Small Cell Lung Carcinoma 142

Interventions

bicalutamide 1 Tamoxifen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00637871 2011-01-24

Casodex - Nolvadex Combination

AstraZeneca

Phase 2 Completed

Gynecomastia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡